The glucagon-like peptide-1 receptor agonist lixisenatide slows motor disability progression in patients with early Parkinson’s disease, suggest findings from the LIXIPARK trial. …more
Low lateralization may reduce the diagnostic accuracy of bilateral inferior petrosal sinus sampling for distinguishing Cushing’s disease from ectopic adrenocorticotropic hormone (ACTH) secretory syndrome, suggests a study published in the Journal of the Endocrine Society in March 2024. …more
Children born to women with epilepsy who take topiramate during the second half of their pregnancy do not have a substantially increased risk of autism spectrum disorder, suggests research published in The New England Journal of Medicine. …more
Severe sepsis during treatment for childhood leukaemia may be associated with an increased risk of moderate-to-severe neurocognitive dysfunction in adulthood, US Study findings indicate. …more
All articles loaded
No more articles to load
Don’t fall behind!
Get the latest headlines – in your specialties of choice – delivered straight to your inbox.showcase
MEET THE SENIOR TEAM
Lynda Williams
medwireNews Deputy Bureau Chief
